Group 1 - The company announced the progress of an asset purchase and related party transaction involving its wholly-owned subsidiary, Lianhuan Pharmaceutical (Anqing) Co., Ltd. [2] - The transaction was approved during the board meeting on September 12, 2025, and the subsequent shareholder meeting on September 30, 2025, with a purchase price of 74.5 million RMB (excluding tax) for certain buildings and land use rights [2] - Lianhuan (Anqing) has paid 50% of the transaction amount and related taxes, and has completed the necessary property rights transfer procedures, obtaining the property certificate from the Anqing Natural Resources and Planning Bureau [3]

Group 1 - The core point of the article is that Zhongtung High-tech (000657) announced that its wholly-owned subsidiary, Rare New Materials, plans to purchase machinery, buildings, and land use rights from Minmetals Tungsten for 123 million yuan (excluding tax) [1] - This transaction is classified as a related party transaction and does not constitute a major asset restructuring [1] - The assessed value of the fixed assets (machinery) is 20.8079 million yuan, the investment property (buildings) is 62.0993 million yuan, and the intangible asset (land use rights) is 39.7569 million yuan, totaling 123 million yuan [1] Group 2 - The purpose of the transaction is to improve the asset structure of Rare New Materials and promote the sustainable development of the company [1]